| |
| WEDNESDAY, OCTOBER 27, 2010 |
| 6:00 PM |
Chairman's Reception (By Invitation Only)
Metro Atlanta Chamber |
| |
| THURSDAY, OCTOBER 28, 2010 |
| 8:00 AM |
Badge Pickup & Exhibit Hall Set Up |
| 8:30 AM |
BioCareer Resource Center
Seasoned recruiters and career experts will share insights on the current job market, high-demand skills and experience, and tips on transitioning your career to fill high-demand needs. |
| |
|
Margot D. King; Founder, Vice President, OnSite Resource Solutions - A ZeroChaos Company, Georgia (Moderator) |
| |
|
Sandra C. Hofmann; ATDC, Georgia Institute of Technology, Georgia |
| |
|
Victoria Hunter; Strategic Recruiter, CDC, Human Capital Management Office, Georgia |
| |
|
Mark McCann; Senior Human Resources Consultant, Integrity HR, Georgia |
|
|
Patricia Romboletti; President, Sage Executive Search, Inc., Georgia |
| 9:30 AM - 4:00 PM |
|
| |
|
| 9:45 AM |
Opening Remarks & Introduction of Plenary Panel
Stephen Hill, BM, BCh, MA, FRCS; Chair, GaBio; President, Abbott Products Inc. formerly Solvay Pharmaceuticals Inc., Georgia |
|
|
|
| 10:00 AM |
PLENARY PANEL: Global Pharmaceutical Company Panel Addresses Public Health |
|
|
Mark L. Rosenberg, MD, MPP; President and Chief Executive Officer, The Task Force for Global Health, Georgia (Moderator) |
| |
|
Ricardo Azziz, MD, MPH, MBA; President, Medical College of Georgia, Georgia |
| |
|
Vasant Narasimhan, MD; President, Vaccines USA, Head, Vaccines North America, Novartis Vaccines and Diagnostics, Inc., Massachusetts |
| |
|
Michael Rosenblatt, MD; Executive Vice President and Chief Medical Officer, Merck & Co., Inc., New Jersey |
|
|
|
| 11:00 AM |
Exhibit Hall Opens Scientific Poster Viewing |
|
|
|
| 11:45 AM |
Official Welcome & Introduction of Lunch Plenary Session
Russell Plumb; Summit Chair; President and Chief Executive Officer, Inhibitex, Inc., Georgia
|
| |
Lunch Plenary Session |
|
|
G. Steven Burrill; Chief Executive Officer, Burrill & Company, California |
| |
|
| 1:00 PM |
CONCURRENT SESSIONS (click on each track for a brief description)
|
| |
Georgia Company Presentations
Track A: Therapeutics, Diagnostics & Vaccines
|
| |
|
Joseph M. Patti, MSPH, PhD; Chief Scientific Officer & Senior Vice President R&D, Inhibitex, Inc., Georgia (Moderator) |
| |
|
William D. Johnston, PhD; Chief Executive Officer, InVasc Therapeutics, Inc., Georgia |
| |
|
George (Barney) Koszalka, PhD; President and Chief Executive Officer, NeurOp, Inc., Georgia |
| |
|
David G. Perryman; President, Chief Executive Officer, Zirus, Georgia |
|
|
|
| |
The Global Center for Medical Innovation
Track B: Med Tech / Device
|
| |
|
Mark G. Allen, PhD; Acting Director, Georgia Electronic Design Center, Georgia Institute of Technology, Georgia (Moderator) |
| |
|
Nicolas A. Chronos, MD, FACC, FESC, FAHA, FRCP; President and Chief Executive Officer, Saint Joseph's Translational Research Institute, Georgia |
| |
|
Wayne Hodges; Executive Director, Global Center for Medical Innovation, Georgia Institute of Technology, Georgia |
| |
|
Jay S. Yadav, MD FACC; Founder and Chief Executive Officer, CardioMEMS, Inc., Georgia |
|
|
|
| |
Case Studies in Global Health Collaboration
Track C: The Role of Life Sciences in Public & Global Health
|
| |
|
Mike Cassidy; President and Chief Executive Officer, Georgia Research Alliance, Georgia (Moderator) |
| |
|
Donald Harn, PhD; Professor and GRA Distinguished Investigator, University of Georgia, Georgia |
| |
|
Mark R. Prausnitz, PhD; Professor and Director, Center for Drug Design, Development & Delivery, Georgia Institute of Technology, Georgia |
| |
|
Paul Spearman, MD;
Nahmias-Schinazi Research Professor and Vice Chair for Research, Department of Pediatrics, Emory University and Chief Research Officer, Children’s Healthcare of Atlanta, Georgia |
|
|
|
| |
Advent of Medicinal and Nutraceutical Plant Research in Georgia and other
Southeastern United States
Track D: New & Exciting Science in Georgia
|
| |
|
Anand K. Yadav, PhD; Professor/Director, Biotechnology and Graduate Programs, Fort Valley State University, Georgia (Moderator) |
| |
|
Nirmal Joshee, PhD; Assistant Professor of Plant Sciences, Fort Valley State University, Georgia |
| |
|
Gnana Viji, PhD; Research Professional, Molecular Biology, Fort Valley State University, Georgia |
|
|
|
| 1:50 PM |
Exhibit Hall Opens and Scientific Poster Viewing |
|
|
|
| 2:00 PM |
CONCURRENT SESSIONS (click on each track for a brief description)
|
| |
Cell-Based Therapies to Address Unmet Patient Needs
Track A: Therapeutics, Diagnostics & Vaccines
|
| |
|
Robert M. Nerem, PhD; Director, Georgia Tech/Emory Center for Regenerative Medicine; Georgia Institute of Technology, Georgia (Moderator) |
| |
|
Arshad Ahmed, MBA; Founding Partner, Scientia Advisors, Massachusetts |
| |
|
Jonathan D. Glass, MD; Director, Neuromuscular Division, Emory University, Georgia |
| |
|
Joseph D. Gold, PhD; Senior Director, Stem Cell Biology, Geron Corporation, California |
|
|
|
| |
Bringing Your Products to Market: Leveraging Georgia Based Expertise
Track B: Med Tech / Device
|
| |
|
Kristy G. Nichols, MS; President, Peachtree BioResearch Solutions, Inc., Georgia (Moderator) |
| |
|
Dan Berman; Chief Executive Officer, PharmaCentra, LLC, Georgia |
| |
|
Linda Braddon, PhD; President, Secure BioMed Evaluations, Georgia |
| |
|
John Durkee, RPh, MBA; Vice President, Business Development & Marketing, Peachtree BioResearch Solutions, Inc., Georgia |
| |
|
Lynn Hood; Top Kernel, Crackerjack Marketing, Georgia |
| |
|
David W. Mullis, Jr., PhD, RAC; President, Mullis & Associates, Inc., Georgia |
| |
|
Charles I. Romano; Senior Director, Phase I & First in Human Research, St. Joseph's Translational Research Institute, Georgia |
|
|
|
| |
Patent Pools-Driving Global Health Initiatives
Track C: The Role of Life Sciences in Public & Global Health
|
| |
|
Susanne Hollinger, PhD, JD; Chief Intellectual Property Officer and Associate Director, Office of Technology Transfer, Emory University, Georgia (Moderator)
|
|
|
Philip T. Chase; Vice President, Legal, Alnylam Pharmaceuticals, Inc., Massachusetts |
| |
|
Melinda F. Moree, PhD; Chief Executive Officer, BIO Ventures for Global Health, California
|
| |
|
Stephen D. Sencer; Senior Vice President and General Counsel (Acting), Emory University, Georgia
|
| |
Expanding Access to Cancer Clinical Trials and Treatments through a Statewide
Research Network
Track D: New & Exciting Science in Georgia
|
| |
|
Nancy M. Paris, MS, FACHE; President and Chief Executive Officer, Georgia Center for Oncology Research and Education, Georgia (Moderator) |
| |
|
Roland Matthews, MD; Associate Professor, Morehouse School of Medicine, Georgia |
| |
|
Amyn M. Rojiani, MD, PhD; E.R. Pund Distinguished Professor / Chairman of the Department of Pathology, Medical College of Georgia, Georgia |
| |
|
Frederick M. Schnell, MD, FACP; Medical Oncologist, Central Georgia Cancer Care, Georgia |
| |
|
Thomas E. Seay, MD, PhD; Medical Oncologist, Atlanta Cancer Care, Georgia |
|
|
|
| 2:50 PM |
Exhibit Hall Opens and Scientific Poster Viewing |
|
|
|
| 3:00 PM |
CONCURRENT SESSIONS (click on each track for a brief description)
|
| |
Funding and Partnering Innovation |
| |
Track A: Therapeutics, Diagnostics & Vaccines |
| |
|
Noël K. Brown; Managing Director, Health Care Investment Banking, Piper Jaffray & Co., New York (Moderator) |
| |
|
David H. Donabedian, PhD, MBA; Vice President, Strategic Alliances to the US CEEDD (Centre of Excellence for External Drug Discovery), GlaxoSmithKline, Massachusetts |
| |
|
Rick Panicucci, PhD; Global Head, Chemical & Pharmaceutical Profiling, Novartis Institutes for BioMedical Research, Inc., Massachusetts |
| |
|
Arthur J. Tipton, PhD; Senior Vice President & Chief Scientific Officer, SurModics, Inc., Alabama |
| |
|
Alison Urkowitz; Associate Director, Team Leader, Research Programs, The Michael J. Fox Foundation for Parkinson's Research, New York |
|
|
|
| |
The Effect of Changes in the 510K Approval Process on Medical Device
Clinical Studies from the Regulatory and Statistical Perspectives
Track B: Med Tech / Device
|
| |
|
Dennis W. King, PhD; President and Chief Executive Officer, STATKING
Consulting, Inc., Ohio (Moderator) |
| |
Lisa B. Peacock, RAC; Vice President, Regulatory Affairs, Femasys Inc., Georgia |
|
|
|
| |
Education, Innovation and Competitiveness |
| |
Track C: The Role of Life Sciences in Public & Global Health |
| |
|
Cinda Herndon-King, PhD; Director, Education Programs, Georgia Bio, Georgia (Moderator) |
| |
|
Michael A. Gerber; President, Atlanta Regional Council for Higher Education, Georgia |
| |
A. Neil Jones; Co-founder and Vice-President of Scientific Operations, Kryosphere Inc., North Carolina |
| |
|
Susan Traiman; Director, Public Policy, Business Roundtable, Washington DC |
|
|
|
| 4:00 PM |
Exhibit Hall Opens and Scientific Poster Viewing |
|
|
|
| 4:15 PM |
PLENARY SESSION: Keynote Address |
| |
Bernie Marcus; Co-Founder of The Home Depot, Inc., and Chairman of the Board of The Marcus Foundation, Georgia
Georgia Bio Honors Bernie and Billi Marcus for Their Commitment in Support of Bioscience Research and Medical Innovation
Atlanta Mayor Kasim Reed and Stephen Hill, BM, BCh, MA, FRCS, Chair, GaBio, President, Abbott Products Inc. (formerly Solvay Pharmaceuticals Inc) |
|
|
|
| 5:15 PM |
Closing Remarks / Announcement of Poster Winners
Russell Plumb; Summit Chair; President and Chief Executive Officer, Inhibitex, Inc., Georgia |
|
|
|
| 5:30 PM |
Reception in Exhibit Hall |
|
|
|
| 7:00 PM |
Exhibit Hall Closed / Summit End |
|
|
|
| |
